Recruiting

TirzepatideThe Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

Sponsor:

Mayo Clinic

Code:

NCT07218445

Conditions

Obesity

Menopause Hot Flashes

Eligibility Criteria

Sex: Female

Age: 46 - 60

Healthy Volunteers: Accepted

Interventions

Tirzepatide

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-30. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-08-18.